Biological and metabolomic insights into RACGAP1-mediated growth and progression of clear cell renal cell carcinoma
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00066.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Wanyi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang,…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, GTPase-Activating Proteins, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), NHC Key Laboratory of Nuclear Technology Medical Transformation, Health Commission of Sichuan Province ().
Abstract (Originalsprache)
We have demonstrated for the first time that CEP55 directly regulated RACGAP1 expression, and downregulation of RACGAP1 blocked ccRCC mitotic division at the G1 phase and induced apoptosis. Targeted and spatial metabolomics analyses showed that RACGAP1 disruption altered levels of multiple metabolites and inhibited ccRCC growth by reprogramming fatty acid, nucleotide, and lipid metabolism. Importantly, spatial imaging of metabolites uncovered intratumor metabolic heterogeneity in ccRCC, providing novel insights into the metabolic landscape of this malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, People's Republic of China.
- Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, People's Republic of Ch…
- NHC Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital, Mianyang, People's Republic of China.
ORCID-Profile: Bei Xu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- NHC Key Laboratory of Nuclear Technology Medical Transformation
- Health Commission of Sichuan Province ()
- Sichuan Science and Technology Program
- 2024 Incubation Project of Mianyang Central Hospital
Zitieren
APA
Li, W., Gan, L., Zang, W., Chen, Y., & Xu, B. (2025). Biological and metabolomic insights into RACGAP1-mediated growth and progression of clear cell renal cell carcinoma. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00066.2025
Vancouver
Li W, Gan L, Zang W, Chen Y, Xu B. Biological and metabolomic insights into RACGAP1-mediated growth and progression of clear cell renal cell carcinoma. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00066.2025
BibTeX
@article{Li2025,
author = {Li, Wanyi and Gan, Lingling and Zang, Wenting and Chen, Yan and Xu, Bei},
title = {Biological and metabolomic insights into RACGAP1-mediated growth and progression of clear cell renal cell carcinoma},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00066.2025}
}
EUVIMED